PF-06282999 is an irreversible inactivator of myeloperoxidase, and currently in clinical trials for the potential treatment of cardiovascular diseases.
For research use only. We do not sell to patients.
Name | PF-06282999 |
---|---|
Iupac Chemical Name | 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide |
Synonyms | PF 06282999;PF06282999; |
Molecular Formula | C13H12ClN3O3S |
Molecular Weight | 325.767 |
Smile | O=C(N)CN(C(N1)=S)C(C2=CC(Cl)=CC=C2OC)=CC1=O |
InChiKey | ICYNYWFGIDGBRD-UHFFFAOYSA-N |
InChi | InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21) |
CAS Number | 1435467-37-0 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% by HPLC |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |